Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials

(2011) C. Heijl et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides

(2011) Guillaume Le Guenno et al.   ARTHRITIS AND RHEUMATISM

Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): Long-term followup of a multicenter longitudinal cohort

(2011) Francisco Silva et al.   ARTHRITIS AND RHEUMATISM

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study

(2011) Mashiko Setshedi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term patient survival in ANCA-associated vasculitis

(2010) O. Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis

(2010) Randi Y. Leavitt et al.   ARTHRITIS AND RHEUMATISM

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

(2010) Julia U. Holle et al.   ARTHRITIS AND RHEUMATISM

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma

(2009) A. Ingvar et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION